期刊
CELL DEATH & DISEASE
卷 13, 期 8, 页码 -出版社
SPRINGERNATURE
DOI: 10.1038/s41419-022-05042-x
关键词
-
类别
资金
- National Natural Science Foundations of China [81730052, 32000970, 82090051, 82090053]
- Natural Science Foundation of Beijing [7214306]
- Tsinghua University Spring Breeze Fund [2021Z99CFZ008]
- Beijing Hospitals Authority' Ascent Plan [DFL20190901]
- Beijing Hospitals Authority Youth Programme [QML20200903]
This study used a human-simulated hepatic spheroid model to demonstrate that Duloxetine (DLX)-induced liver injury is a human CYP450 specific, metabolism-dependent, oxidative stress triggered complex hepatic injury. They also discovered that a novel compound S-071031B showed lower hepatotoxicities than DLX. This research presents the human-relevant model as an ideal system for evaluating DLX-induced hepatotoxicity and exploring related mechanisms.
Duloxetine (DLX) has been approved for the successful treatment of psychiatric diseases, including major depressive disorder, diabetic neuropathy, fibromyalgia and generalized anxiety disorder. However, since the usage of DLX carries a manufacturer warning of hepatotoxicity given its implication in numerous cases of drug-induced liver injuries (DILI), it is not recommended for patients with chronic liver diseases. In our previous study, we developed an enhanced human-simulated hepatic spheroid (EHS) imaging model system for performing drug hepatotoxicity evaluation using the human hepatoma cell line HepaRG and the support of a pulverized liver biomatrix scaffold, which demonstrated much improved hepatic-specific functions. In the current study, we were able to use this robust model to demonstrate that the DLX-DILI is a human CYP450 specific, metabolism-dependent, oxidative stress triggered complex hepatic injury. High-content imaging analysis (HCA) of organoids exposed to DLX showed that the potential toxicophore, naphthyl ring in DLX initiated oxidative stress which ultimately led to mitochondrial dysfunction in the hepatic organoids, and vice versa. Furthermore, DLX-induced hepatic steatosis and cholestasis was also detected in the exposed EHSs. We also discovered that a novel compound S-071031B, which replaced DLX's naphthyl ring with benzodioxole, showed dramatically lower hepatotoxicities through reducing oxidative stress. Thus, we conclusively present the human-relevant EHS model as an ideal, highly competent system for evaluating DLX induced hepatotoxicity and exploring related mechanisms in vitro. Moreover, HCA use on functional hepatic organoids has promising application prospects for guiding compound structural modifications and optimization in order to improve drug development by reducing hepatotoxicity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据